Arvinas

With a diverse background in medical technology, human physiology, and cell biology, Scott Campbell brings a unique perspective to #Arvinas. Scott is deeply passionate about Arvinas' novel protein degrader technology, which he finds incredibly exciting, especially as he sees its potential applications across various therapeutic areas. When he’s not working, Scott loves to explore the mountains of Colorado with his wife. They’re on a mission to complete 52 hikes this year and have already summited the famous Pikes Peak! Fun fact: Scott starts his day at 3 am with a workout, followed by some reading and a walk with his dog. He’s also a self-proclaimed pizza lover, with a soft spot for the famous #NHV and New York-style pies! Learn more about other members of #TeamArvinas here: https://rb.gy/lhp36x #TPD #WorkAtArvinas #EmployeeExperience #CompanyCulture?

Our Chief Scientific Officer, Angela Cacace, recently shared her insights with #Arvinas Chairperson, CEO and President Chief Scientific Officer, John Houston in an inspiring conversation about her career journey, the future of #STEM, and leadership in neuroscience. They also explored the importance of diversity in leadership roles and the unique challenges within the neuroscience space. Angela's story is a powerful reminder of the importance of perseverance, passion, and collaboration in driving progress in STEM. Check out the vlog here: https://bit.ly/3CMKXFO #TeamArvinas #Leadership #WomenInSTEM #Neuroscience #DiversityInSTEM #Innovation

Arvinas’ PROTAC?protein degraders, or PROteolysisTArgeting Chimeras, are designed to harness the body’s natural protein disposal system to destroy disease-causing proteins. We are working to propel the future of drug research with targeted protein degradation. ? Check out this #ScienceOfPROTAC video to hear Angela Cacace, Ph.D., Chief Scientific Officer, explain how Arvinas’ PROTACs designed to work. Learn More:?https://bit.ly/40hFscb ? #Innovation #Science

#HCPs check out our new Arvinas Medical Oncology LinkedIn page dedicated to communicating emerging science from #Arvinas and providing disease state education to US HCPs.

Check out this insightful op-ed from Life Science Leader on advancing next-generation treatments for breast cancer and the role of strategic partnerships in driving innovation. At #Arvinas, we aim to develop novel therapies with the intention to improve patient outcomes, and we’re proud to collaborate with experts across the industry. A special thanks to our own Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership and Christina Derleth, Vice President, Breast Cancer Therapeutic Area Development Head, Pfizer Oncology for contributing to this important conversation. Together, we’re working to push the boundaries of cancer research. Read more about how partnerships aim to shape the future of breast cancer treatments: https://bit.ly/4fRrdPZ #BreastCancer #CancerResearch #PartnershipsInScience #BiotechInnovation

#NEWS: Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update. Read the release here: https://bit.ly/3Ajd6nc

#TeamArvinas’ very own Sheryl Gough, PhD Gough, Associate Director, Biology-Oncology, was selected as a Connecticut Technology Council 2024 Women of Innovation? finalist in the Corporate Innovation and Leadership, Small-Medium Business Category. Join us in congratulating Sheryl on this incredible honor and celebrating her passion for excellence in innovation and check out her #WomenInScience story where she discusses her career path and the importance of mentorship. Learn More: https://bit.ly/4dYyaNK #ThoughtLeadership #WomenInScience #WomenInSTEM?

#TeamArvinas colleagues once again made a difference during our third annual #Arvinas Impact Day! Through various volunteer activities, during #ArvinasImpactDay2024, we supported environmental conservation efforts, youth programs, and other meaningful causes within the communities where we work and live. Whether helping preserve the Long Island Sound with Save the Sound, beautifying the Boys & Girls Clubs of Greater New Haven, revitalizing trails and cutting brush with Friends of East Rock Park or volunteering in their own communities, our employees demonstrated their passion for giving back. Thank you to all who participated to make a positive impact and carry out our core value of #Community! Learn more:?https://bit.ly/3YfAidV

As a Director in Regulatory, Chemical, Manufacturing, and Controls (CMC), Zhigang Cheng plays a crucial role in ensuring our drug development process aligns with global regulatory standards. His expertise is invaluable in guiding our teams through complex submissions and navigating regulatory landscapes. Beyond his professional accomplishments, Ken is also a passionate marine enthusiast. He spends his free time tending to his saltwater aquarium, where he carefully balances the delicate ecosystem and admires the beauty of his underwater world. Learn more about other members of #TeamArvinas here: https://rb.gy/lhp36x ?#TPD #WorkAtArvinas #EmployeeExperience #CompanyCulture?

Regular screenings can be a key step in supporting early detection efforts and staying informed about your health #BCAM